Patent Assignment
Reel/Frame 068826/0711
Patent Security Agreement
Recorded: 2024-09-03
Pages: 8
Assignor
IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Executed: 2024-09-03
Assignee
BIOPHARMA CREDIT PLC
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(25)
Methods and Compositions for Treatment of Attention Deficit Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Method of Treatment of Attention Deficit Hyperactivity Disorder
Methods of Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methods of Treatment of Attention Deficit Hyperactivity Disorder
Methods for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application:
17/316,252 →
Publication:
US 2021/0267957
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Methylphenidate Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Application:
18/057,819 →
Publication:
US 2023/0120738
Compositions for Treatment of Attention Deficit Hyperactivity Disorder
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 29, 2012
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 029424/0359 →
Master Development Agreement
Oct 31, 2013
From: HIGHLAND THERAPEUTICS, INC.
To: PHARMAFORM
Reel/Frame 031609/0883 →
Assignment of Assignor's Interest
Oct 31, 2013
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 031552/0812 →
Assignment of Assignor's Interest
Nov 15, 2013
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 031733/0639 →
Corrective Assignment to Correct Assignee/Assignor Names; Previously Recorded at Reel 031609 Frame 0883. Assignor(S) Hereby Confirms the Assignment.
Feb 19, 2014
From: FORMULATION TECHNOLOGIES L.L.C. D/B/A PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032425/0435 →
Assignment of Assignor's Interest
Apr 3, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032611/0146 →
Assignment of Assignor's Interest
Apr 3, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0126 →
Assignment of Assignor's Interest
Apr 3, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0122 →
Assignment of Assignor's Interest
Apr 3, 2014
From: FORMULATION TECHNOLOGIES, L.L.C. D/B/A PHARR
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032611/0137 →
Assignment of Assignor's Interest
Apr 3, 2014
From: FORMULATION TECHNOLOGIES, L.L.C. D/B/A PHARR
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032611/0130 →
Assignment of Assignor's Interest
Apr 3, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032611/0144 →
Assignment of Assignor's Interest
Apr 3, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0124 →
Assignment of Assignor's Interest
Apr 3, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032611/0128 →
Assignment of Assignor's Interest
Apr 25, 2014
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032799/0978 →
Assignment of Assignor's Interest
Apr 25, 2014
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 032800/0028 →
Assignment of Assignor's Interest
Apr 25, 2014
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC, DBA PHARMAFORM
Reel/Frame 032799/0931 →
Master Development Agreement
May 8, 2014
From: FORMULATION TECHNOLOGIES L.L.C. D/B/A PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 032845/0794 →
Assignment of Assignor's Interest
Jan 7, 2015
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034654/0547 →
Assignment of Assignor's Interest
Jan 7, 2015
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034730/0474 →
Assignment of Assignor's Interest
Jan 7, 2015
From: FORMULATION TECHNOLOGIES LLC DBA PHARMAFORM
To: HIGHLAND THERAPEUTICS INC.
Reel/Frame 034729/0571 →
Assignment of Assignor's Interest
Jan 7, 2015
From: LICKRISH, DAVID
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034741/0294 →
Assignment of Assignor's Interest
Jan 7, 2015
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
Reel/Frame 034730/0421 →
Assignment of Assignor's Interest
Jan 7, 2015
From: HIGHLAND THERAPEUTICS, INC.
To: IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
Reel/Frame 034652/0787 →
Assignment of Assignor's Interest
Jan 7, 2015
From: ZHANG, FENG
To: FORMULATION TECHNOLOGIES, LLC
Reel/Frame 034731/0809 →
Assignment of Assignor's Interest
Jan 7, 2015
From: FORMULATION TECHNOLOGIES, LLC DBA PHARMAFORM
To: HIGHLAND THERAPEUTICS, INC.
Reel/Frame 034741/0625 →